Alexion Pharmaceuticals Inventory

As of the most recent data (March 2021), ALXN shows a inventory of $800M. That compares with $590M in the prior-year period — up 37.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALXN's inventory is now $800M (was $590M) — a 37.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Alexion Pharmaceuticals is outperforming or lagging.

Tracking ALXN's inventory over time shows whether Alexion Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $800M That compares with $590M in the prior-year period — up 37.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Alexion Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $800M) with ownership activity and broader fundamentals.

Alexion Pharmaceuticals's inventory is $800M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.